Ten63
Leveraging advanced AI and physics-based models to design breakthrough drugs for cancer and other diseases once thought impossible to treat
Healthcare & Biotech
Vision
Ten63 Therapeutics is focused on improving human health by developing better, more durable therapeutics against cancer and some of the world’s most lethal diseases. We are leveraging our proprietary in silico platform BEYOND to generate novel therapeutics to hit previously undruggable targets while bringing the paradigm of durable response into early drug design through our unique ability to predict and overcome drug resistance.
Sub-Industries
HealthTech
Oncology Therapeutics
Testimonial
Related Companies
KindBio
The future of organ replacement
Salem, NH, USA
The Embryo Corporation
Scalable embryo gene editing to build the next generation of animal life
Austin, TX, USA
Paterna Biosciecnes
In vitro gematogenesis platform company to address male and female intertility
Salt Lake City, UT, USA
Proton Intelligence
Real-time wearable potassium monitoring
Vancouver, Canada
Origenity
AI-driven cell design, from next-generation genetic medicines to expanding what life can be
San Francisco, USA
Deep Root Biolabs
Plant-powered synthetic biology turning polluted soil into clean ground and reclaimed critical minerals
Baltimore, MD, USA
LightHearted AI
Revolutionizing Point-of-Care Cardiac Detection Using Photonics and AI
London, UK
